0.01
0.00%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Novelstem International
From its filings with the US Securities and Exchange Commission
Novelstem International is based in Boca Raton, Florida and is incorporated in Florida. Its shares trade on OTC under the ticker NSTM. The SEC classifies its business as retail-retail stores, nec. In the fiscal year to 31 December 2012, it reported revenue of $616,338.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 12 Nov 1993
- Employees
- 15
- Website
- novelstem.com ↗
- Head office
- 2255 GLADES RD, BOCA RATON, FL, 33431
- Incorporated in
- FL
- Classification
- Retail-Retail Stores, NEC
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Jan LoebExecutive Chairman of the Board, Chief Executive Officer, President, since 2018$27,170
- Ms. Christine JenkinsChief Financial Officer, Vice President, Secretary$58,725
- Mr. Jerry WolaskyDirector$27,170
- Ms. Tracy CliffordIndependent Director$27,170
- Mr. Eric RichmanIndependent Director$27,170
- Mr. Mitchell RubensteinIndependent Director, since 1993$27,170
- Mr. David SeltzerIndependent Director$27,170
- Mr. William JonesInvestor Relations, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Novelstem International Corp possesses a robust intellectual property portfolio, including patents and trademarks. This provides a competitive advantage by protecting their innovative technologies and branding, positioning them as a leader in the industry.
- The company offers a wide variety of products catering to different customer needs. This diversification helps Novelstem International Corp to mitigate risks associated with relying on a single product line and enables them to capture a broader market share.
Weaknesses
- Novelstem International Corp currently has a limited international presence, primarily operating within domestic markets. This exposes the company to risks associated with economic fluctuations and regulatory changes specific to a particular region.
- The company heavily depends on a few key suppliers for sourcing raw materials and components. Any disruption in the supply chain could adversely affect the production process, resulting in delays or increased costs for Novelstem International Corp.
Opportunities
- The company has the opportunity to expand into emerging markets, which offer untapped potential and new customer segments. By establishing a presence in these markets, Novelstem International Corp can capitalize on increasing consumer demand and drive revenue growth.
- Advancements in technology present opportunities for Novelstem International Corp to develop innovative products and enhance their existing offerings. By investing in research and development, the company can stay ahead of competitors and meet evolving customer expectations.
Threats
- The industry in which Novelstem International Corp operates is highly competitive, with numerous players vying for market share. Intense competition can lead to price wars, reduced profit margins, and challenges in acquiring new customers.
- The company faces potential threats from changes in regulations and compliance requirements. Adapting to new rules may incur significant costs and impact the business operations of Novelstem International Corp.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.